BCL2 and metastatic malignant neoplasm in the lymph nodes: While some studies report no correlation between Bcl-2 expression and clinical outcomes [117,118,119,120,121], other investigations have linked its overexpression to lymph node metastasis, advanced stage, poor differentiation, increased recurrence, and radioresistance [165].